SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

A sharp broad-market selloff, which traders link to the Democrats midterm gains and fears that political pushback could slow AI and data-center expansion, has put SPY in focus as tech and semiconductor shares unwind. The community is divided between calling the decline an overreaction and buying the dip versus expecting further downside amid volatility and selling pressure.

Netlist, Inc. engages in the design, manufacture and sale of memory subsystems for the computing and communications markets. Its products include enterprise SSD, embedded flash, memory module, lightning DDR5 DIMM, SK hynix, AI server. The company was founded by Jayesh Bhakta, Chun Ki Hong and Christopher Lopes in June 2000 and is headquartered in Irvine, CA.

Netlist Inc

NLST is under pressure amid a broad selloff in technology and memory stocks, with traders debating whether concerns about AI/data-center investment and policy risks or company-specific factors are driving the decline. Many are treating the pullback as a buying opportunity ahead of the Q3 report, while watching for an SK Hynix agreement and developments in Netlists Kingston litigation.

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.

Rigel Pharmaceuticals

Rigels quarterly results and early VEPPANU launch are driving discussion: traders are encouraged by the drugs initial uptake and record product sales, but some focus on the earnings miss, weaker margins, and cash burn. The stocks sharp decline has sharpened the debate over whether VEPPANUs growth potential outweighs the disappointing headline results.

Listed Funds Trust - Roundhill Magnificent Seven ETF

Roundhill Magnificent Seven ETF

MAGS is under pressure as traders question whether Big Techs heavy AI and data-center spending will generate returns quickly enough to offset its effect on free cash flow. The community is split between fears of a deeper tech correction and views that the selloff is a rotation or pullback creating a buying opportunity.

X-Energy, Inc. engages in the development of advanced small modular nuclear reactors and fuel technology for clean energy generation. Its solutions include Xe-100 and TRISO-X. The company was founded by Kam Ghaffarian and Eben Mulder in 2009 and is headquartered in Rockville, MD.

X-Energy Inc. - Ordinary Shares- Class A

X-Energy Inc

XE is drawing attention amid a sharp selloff, with traders citing broader weakness in nuclear stocks and concerns about post-IPO share supply and bearish analyst coverage. Some are buying the dip on the strength of Amazon-backed reactor projects and federal support, while others worry that commercialization and meaningful revenue remain years away.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings disappointing Q3 results and lowered full-year outlook triggered a sharp selloff, with traders criticizing rising costs and managements heavy investment in its Predictions business. The main debate is whether that investment can build a growth engine or instead leaves DraftKings vulnerable to competition from Kalshi and Polymarket and delays profitability.

Sezzle, Inc. engages in the operation of a digital payment platform that enables bank-to-bank transfer of money between consumers and businesses. The company was founded by Charlie G. Youakim, Killian Brackey and Paul V. Paradis on January 4, 2016 and is headquartered in Minneapolis, MN.

Sezzle Inc.

Sezzles Q3 results beat expectations and management raised its FY2026 outlook while issuing a positive initial FY2027 forecast, fueling a sharp rally. Bulls point to continued growth and profitability, while some traders warn that valuation and a slower projected growth pace could weigh on the stock; short-squeeze talk is speculative.

Teradyne, Inc.. The Group's principal activity is to design, manufacture, sell and service automatic test equipment for electronic companies. It operates in two segments: Semiconductor Test Systems and System Test Group. Semiconductor Test Systems segment designs, manufactures, sells and supports Semiconductor Test products and services on a world wide basis. Systems Test Group segment is comprised of 3 business units: Mil/Aero, Commercial Board Test and Diagnostic Solutions. It also operates in the Semiconductor Test; Military/Aerospace test, Commercial Circuit Board test and Automotive Diagnostics test. On 14-Nov-2008, it acquired Eagle Test Systems Inc, On 24-Jan-2008, it acquired Nextest Systems Corporation ('Nextest').

Teradyne, Inc.

Teradynes sharp selloff despite a strong quarterly beat is driving discussion, with traders pointing to cautious near-term guidance, margin pressure and valuation concerns. Some see the drop as a buying opportunity, while others question whether AI-related chip-testing demand can sustain the stocks prior gains.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

BMNR is under pressure amid a broad crypto and tech selloff, with traders linking its decline to weakness in Bitcoin and Ethereum. Many complain that the stock is falling harder than ETH and criticize Tom Lees stewardship, while others see the discount to asset value and share buybacks as reasons to buy the dip.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is caught in a sharp semiconductor selloff as traders worry that post-midterm calls for tighter data-center rules could slow AI infrastructure spending and chip demand. The community is split between seeing the drop as an overreaction and buying opportunity, and expecting more downside if AI-capex growth or data-center expansion slows.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

HRMY Q3 Earnings Miss Estimates on Higher Costs Despite Wakix Growth

Harmony Biosciences' Q3 earnings missed estimates as higher costs weighed on profits, while Wakix demand and pipeline progress supported its 2026 revenue outlook.

ZTS Q3 Earnings Top Estimates, 2026 Profit Outlook Improves, Stock Up

Zoetis beats third-quarter earnings and revenue estimates. Livestock sales growth partially offsets weakness in companion animal products.

Viatris Q3 Earnings Beat on Stronger Margins, Revenues Fall Y/Y 

VTRS beats Q3 earnings estimates on stronger margins and raises 2026 earnings guidance, despite revenue miss and persistent supply constraints.

Lexicon Pharmaceuticals (LXRX) Reports Q3 Loss, Tops Revenue Estimates

Lexicon (LXRX) delivered earnings and revenue surprises of +50.00% and +3.21%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

Agilent Technologies' Q4 Earnings on Deck: What's in Store for the Stock?

Agilent Technologies gears up for Q4 fiscal 2026 earnings, with revenues and EPS growth expected amid strength in chromatography, spectroscopy and consumables.

Ocugen's Q3 Earnings Match Estimates, Revenues Beat, Stock Rises

OCGN's Q3 revenues beat estimates. Shares surge 17.4%. Advancing gene therapy programs target three BLA submissions by 2028.

Teva Q3 Earnings Beat Estimates, 2026 Revenue View Raised, Stock Up

Teva's Q3 earnings beat estimates as strong branded drug sales fueled growth, prompting higher 2026 revenue and product sales guidance.

CORT's Q3 Earnings Beat, Higher Product Sales Aid Y/Y Revenues

Corcept's Q3 earnings and revenues beat estimates, driven by strong Lifyorli uptake and higher Korlym sales, as the company advances its pipeline.

AMRX Q3 Earnings & Sales Beat Estimates, FY'26 Guidance Raised

Amneal tops Q3 estimates as strong Affordable Medicines and Specialty growth drives higher 2026 guidance and boosts its growth outlook.

4 Biotech Stocks Likely to Outpace Q3 Earnings Estimates

Four biotech stocks, including TG Therapeutics and Immunome, show positive Earnings ESPs and favorable Zacks Ranks, positioning them for potential third-quarter earnings beats.

TG Therapeutics is a fully integrated, commercial stage, biotechnology company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI® (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features. For more information, visit www.tgtherapeutics.com, and follow us on X (formerly Twitter) @TGTherapeutics and on LinkedIn.

TG Therapeutics Inc

S&P 500, Nasdaq Futures Rise Premarket After Wall Street’s Worst Week In Months: AAPL, PLTR, GOOGL, INTC, TGTX In Focus

Equity

Bullish Sentiment

<ul class="summary-bullets"><li>Oil prices dropped more than 4% as hopes for diplomatic progress between the U.S. and Iran eased concerns about potential supply disruptions.</li><li>Apple and Palantir were in focus ahead of their quarterly results after Monday’s close, with investors watching Apple's product strategy and Palantir's AI-driven growth.</li><li>Investors will also be tracking Monday's Manufacturing PMI and ISM Manufacturing PMI releases, with the US midterm elections scheduled for Nov. 3.</li></ul>U.S. stock futures edged higher early on Monday, recovering some ground after Wall Street ended the previous week in the red. Investors are gearing up for a busy week featuring corporate earnings, important jobs data and the U.S. midterm elections on Nov. 3. S&amp;P 500 futures rose 0.5%, while Nasdaq-100 futures gained 0.83%. Dow Jones Industrial Average futures added 0.5%.Earlier, on Friday, U.S. stock indices&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/s-and-p-500-nasdaq-end-third-straight-week-lower-as-investors-move-away-from-tech-ai-amzn-intc-lly-rblx-in-focus/cZUKKlTR9cJ">closed lower</a>, with the S&amp;P 500 and Nasdaq ending October in negative territory as investors pulled back from technology and AI-related stocks. Disappointing third-quarter earnings from many companies and concerns that rising AI capital expenditure could strain cash flows weighed on sentiment.&nbsp;The S&amp;P 500 fell 2% on Friday, while the Nasdaq 100 dropped 3.5% and the Dow Jones Industrial Average slipped 1.1%. The Russell 2000, which tracks small-cap stocks, declined 1.7%. The Nasdaq 100 lost around 6.5% in October, marking its worst monthly performance since March 2025.<h2 class="st-heading-2">Oil Prices Slide As US-Iran Peace Hopes Ease Supply Fears</h2>Oil prices fell more than 4% on Monday as optimism over diplomatic efforts to end the U.S.-Israeli war with Iran eased immediate concerns about potential supply disruptions. Brent crude futures for January delivery dropped 4.21% to $108.66 a barrel by 5 a.m. ET, while US West Texas Intermediate (WTI) futures declined 4.1% to $99.85 a barrel. The pullback followed strong gains in recent sessions, with no major escalation over the weekend and continued negotiations prompting some investors to book profits.<h2 class="st-heading-2">The Tech Radar</h2>Apple (AAPL):&nbsp;The stock slipped 0.52% in premarket trading on Monday as investors awaited the company’s fiscal fourth-quarter results, due after the closing bell. The report will be Apple’s first under new CEO John Ternus and comes after a major product push that included the unveiling of a foldable iPhone and touchscreen MacBooks, both of which have received mixed reviews. Investors will also watch for details on how Apple plans to absorb higher memory costs without passing them on to consumers or hurting demand. Questions over hinge and screen issues affecting the new iPhone Duo are also likely to feature, despite longer delivery times suggesting strong interest in the device.Palantir Technologies (PLTR):&nbsp;Shares gained 1.3% in premarket trading on Monday ahead of the company’s third-quarter results, due after the closing bell. The earnings report will test investor confidence in the durability of its AI-driven growth, even as analysts anticipate another strong quarter. Revenue is expected to climb 85% year over year to $2.18 billion, slowing from the 93% growth recorded in the second quarter, while adjusted earnings are forecast to rise 94% to $0.41 per share, according to Koyfin. PLTR has also shown relative resilience amid October’s retreat in AI-linked stocks. After reaching a record high early in the month, the shares ended October down just 1.5%.Alphabet (GOOGL):&nbsp;Shares were up 1.33% in early premarket trading, attempting to recover after a steep weekly decline. The stock fell 12.6% last week, marking its sharpest weekly drop since 2008. Dan Niles of Niles Investment Management said recent Big Tech earnings had exposed the risks posed by AI, describing the results as “more trick than treat for technology investors.” He pointed to Alphabet’s Search revenue missing estimates for a second consecutive quarter, alongside the company’s first misses on both total revenue and EPS since late 2022, as factors fuelling concerns about AI-driven disruption to its core business. However, Search queries reached a five-year high, and Niles sees Google as a potential consumer AI winner, citing its distribution through Android devices.Alphabet also launched its second euro bond sale of the year, gauging investor appetite less than a week after disappointing third-quarter results triggered a record slump in its shares and widened credit spreads across the technology sector.Intel (INTC):&nbsp;Shares rose 0.8% in premarket trading on Monday, following a 24% plunge last week after the chipmaker issued a weaker-than-expected fourth-quarter outlook. The decline came despite a strong third quarter, with revenue climbing 21% year over year to $16.5 billion and adjusted earnings beating estimates at $0.52 per share. However, Intel warned that supply constraints and softer PC demand could weigh on its performance in the coming quarter.<h2 class="st-heading-2">Trending Stocks</h2>TG Therapeutics (TGTX): Shares rose nearly 0.82% in early premarket trading on Monday ahead of the company's third-quarter 2026 results, due before the opening bell. Analysts expect earnings of around $0.36 per share on revenue of approximately $245 million, according to Fiscal AI data. In the previous quarter, the company beat revenue estimates but missed EPS expectations, while raising its full-year guidance on the back of BRIUMVI sales. TGTX shares hit a fresh&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/tgtx-stock-hits-fresh-52-week-high-ahead-of-earnings-amid-buyout-buzz/cZULRP2R9cR">52-week high</a> on Friday, extending a multi-day rally ahead of the earnings announcement and amid buyout speculation.Amgen (AMGN):&nbsp;The stock declined 0.04% in premarket trading on Monday ahead of the company’s earnings report, due after the market closes on Tuesday. Investors will be watching for an update on its obesity drug, MariTide. The Phase 3 Maritime program is testing the treatment for weight management, as well as cardiovascular disease, heart failure and sleep apnoea. Another trial is examining less frequent dosing, with injections every eight weeks or once a quarter for patients switching from weekly treatments such as tirzepatide or semaglutide. If approved, the longer dosing intervals could make MariTide an attractive option for patients.Other tickers trending on Stocktwits at the time of writing included Oracle (ORCL), Wendy’s Co. (WEN), and ServiceNow (NOW), among others.<h2 class="st-heading-2">What Else To Watch On Monday&nbsp;</h2>On the earnings front, Apple (AAPL) is scheduled to report its results after Monday's closing bell. Palantir Technologies (PLTR), Roku (ROKU), and ON Semiconductor (ON) are also among the companies due to release their earnings after the market closes.On the economic calendar, investors will track the Manufacturing PMI and ISM Manufacturing PMI releases due Monday. Both indicators offer insights into industrial activity and the broader health of the US economy.<h2 class="st-heading-2">SPY, QQQ, DIA: Retail Sentiment</h2>Retail sentiment toward the&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF (SPY)</a>, which tracks the S&amp;P 500, fell to ‘neutral’ from ‘bullish’ over the past 24 hours. Sentiment toward the&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust (QQQ)</a>, which tracks the Nasdaq 100, and the&nbsp;<a href="https://stocktwits.com/symbol/DIA">SPDR Dow Jones Industrial Average ETF Trust (DIA)</a> remained ‘bearish,’ unchanged during the same period.Also read:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/uso-uco-slide-as-brent-retreats-on-us-iran-de-escalation-hopes-but-goldman-reportedly-sees-oil-at-105-in-december/cNG9o3XR92F">USO, UCO Slide As Brent Retreats On US-Iran De-escalation Hopes – But Goldman Reportedly Sees Oil At $105 In December</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

The NASDAQ MarketSite in Times Square is seen November 20, 2006 in New York City. (Photo by Spencer Platt/Getty Images)

U.S. stock futures edged higher early on Monday, recovering some ground after Wall Street ended the previous week in the red. Investors are gearing up for a busy week featuring corporate earnings, important jobs data and the U.S. midterm elections on Nov.

S&P 500, Nasdaq Futures Rise Premarket After October Selloff: AAPL, PLTR, GOOGL, INTC, TGTX In Focus

U.S. stock futures edged higher after a bruising week for Wall Street, as investors looked ahead to major earnings, economic data, and the Nov. 3 midterm elections. Oil prices fell on hopes of progress in US-Iran negotiations.

Apple Inc

AMGEN Inc.

Alphabet Inc Class A

Intel Corp

Palantir Technologies Inc

Fundamental investor

Technical trader

A mix of both

Fundamental analysis looks at earnings, valuation, and business quality, while technical analysis focuses on chart patterns, price action, and indicators, and many investors blend the two. How do you decide what to buy: fundamentals or technicals? Vote and explain your reasoning in the comments.

Feed

News

Sentiment

Earnings

Fundamentals

Info

TGTX News